Delivery Order SPE2DB20D7066-SPE2DB25FC3AF
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,306.98, is for the delivery of Cephalexin 250 mg/5 ml suspension in 200 ml bottles. The contract is a firm fixed-price delivery order with a period of performance ending on February 7, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,722.83 Firm Fixed Price Delivery Order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of May 23, 2023 and was awarded on May 22, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,460.70, is for the supply of Cephalexin 250 mg/5 ml suspension in 100 ml quantities. The contract has a July 12, 2024 completion date and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,725.49 firm fixed-price delivery order is for the supply of Cephalexin 250 mg/5 ml suspension, a generic antibiotic medication. The contract has an ultimate completion date of September 27, 2023 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $1,789.64, is for the delivery of 4,563,942,071 units of the pharmaceutical product Cephalexin 250 mg/5 ml suspension in 100 ml containers. This delivery order does not have a set-aside designation. The award is part of a larger, single-award indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,239,826 units of Cephalexin 250 mg/5 ml suspension in 100 ml bottles. The fixed-price delivery order, valued at $2,218.57, has a period of performance ending on September 21, 2023. The contract was awarded on September 20, 2023 and did not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of Cephalexin 250 mg/5 ml suspension medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,251.10 and an ultimate completion date of January 25, 2024. AmerisourceBergen Drug Corp. is the prime contractor, and the contract does not have a set-aside designation. This award is associated with a larger Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,489.91, is a delivery order for 4,562,888,391 units of Cephalexin 250 mg capsules. The contract has an ultimate completion date of November 24, 2023 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a $14,943.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,563,045,324 units of Cephalexin 250 mg/5 ml suspension with a 100 ml volume. The contract, which has an ultimate completion date of December 11, 2023, was not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency's (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,383.19, is for the supply of 4563084300 - Cephalexin 250 mg/5 ml suspension, 100 ml. The contract has a completion date of December 14, 2023. No set-aside was used for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract...